InvestorsHub Logo
Followers 43
Posts 10679
Boards Moderated 0
Alias Born 07/15/2007

Re: None

Thursday, 10/30/2014 10:30:15 PM

Thursday, October 30, 2014 10:30:15 PM

Post# of 146210
NNVC

I cut this from a post on another board.

The bill, which would likely be introduced next month, would add Ebola to the FDA’s priority review voucher program, which Congress established in 2007 to encourage development of new medicines for tropical diseases. Ebola is currently not on that list.
Here’s how the voucher system currently works:: A drug maker that develops a treatment for a qualifying tropical disease receives a voucher for an FDA priority view for another medicine, which means the agency would be obligated to review the medicine in six months instead of the standard 10 months.


NNVC EBOLACIDE could get a voucher!


Echo20
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News